It is not easy to pick a name for a drug. Not only are there chemical and non-proprietary names to consider, but companies also need to assign a market-friendly brand name that can be used easily by pharmacists, physicians, patients and other stakeholders. Moreover, these names need to be unique so there is no confusion between similar sounding drugs.
In this month’s cover story, we explore the role of several international bodies in naming new therapies, and how this process is changing in light of increasing numbers of cell and gene therapies, and the growth of biosimilars.
Go deeper with GlobalData
Also, in this issue, we explore how gene therapies could transform the treatment of sickle cell disease. This issue also features a roundup of key trends set to affect the European biotech industry and the UK’s pharmaceutical manufacturing landscape. All this and the latest news and analysis on the pharmaceutical and biotech industry.
Read the latest issue of Pharma Technology Focus for all this and insights, and analysis from the pharmaceutical industry.
You can also subscribe here to receive email notifications when a new issue is available.
See Also:
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
